Dania Therapeutics ApS — Credit Rating and Financial Key Figures

Dania Therapeutics ApS (CVR number: 42523925) is a company from KØBENHAVN. The company recorded a gross profit of -8836.7 kDKK in 2024. The operating profit was -10.3 mDKK, while net earnings were -9556.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -58.4 %, which can be considered poor and Return on Equity (ROE) was -86.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -59.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Dania Therapeutics ApS's liquidity measured by quick ratio was 9.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.